Healthcare Cold Chain Logistics Market Forecast with Size and Share Analysis 2026 to 2035

Report Id: 1917 Pages: 180 Last Updated: 23 January 2026 Format: PDF / PPT / Excel / Power BI
Share With : linkedin twitter facebook

Segmentation of Healthcare Cold Chain Logistics Market :

Healthcare Cold Chain Logistics Market By Packaging / Container Type-

  • Active temperature-controlled ULDs
  • Hybrid containers
  • Passive reusable bulk shippers (pallet)
  • Passive parcel shippers (single-use/reusable)
  • Dry ice & deep-freeze solutions
  • LN₂ dry vapor shippers & cryo dewars
  • Refrigerants (PCM, gel packs) & payload conditioning

Healthcare Cold Chain Logistics Market

 Healthcare Cold Chain Logistics Market By Services Line-

  • Transportation & express
  • Warehousing & distribution
  • Packaging & containerization
  • Temperature monitoring & visibility
  • Value-added services
  • Direct-to-patient / home healthcare logistics
  • Clinical trial logistics

Healthcare Cold Chain Logistics Market By Temperature Range-

  • Controlled ambient (15–25 °C)
  • Refrigerated/cold (2–8 °C)
  • Frozen (−20/−30 °C)
  • Deep-frozen (≤−80 °C)
  • Cryogenic/LN₂ (≤−150 °C; dry vapor shippers)

Healthcare Cold Chain Logistics Market By Product Type-

  • Small-molecule pharmaceuticals
  • Biologics & vaccines
  • Cell & gene therapies (CGT)
  • Clinical trial materials (IMP, comparators, ancillaries)
  • Diagnostic reagents & biospecimens
  • Blood, plasma & specialty biologics

Healthcare Cold Chain Logistics Market By Mode Of Transport-

  • Air
  • Road
  • Ocean
  • Rail
  • Multimodal/intermodal

Healthcare Cold Chain Logistics Market By Application-

  • Commercial distribution
  • Clinical trials (phase I–IV)
  • Direct-to-patient & decentralized trials
  • Returns, refurb & reverse logistics
  • Emergency/stock-out mitigation & surge response

Healthcare Cold Chain Logistics Market By End User-

  • Pharma & biotech manufacturers
  • Vaccines & biologics producers
  • CDMOs/CMOs
  • CROs/clinical sites & labs
  • Hospitals, blood banks & diagnostics networks
  • Government & NGOs (EPI/UNICEF/PAHO)

Healthcare Cold Chain Logistics Market By Region-

  • North America-
    • The US
    • Canada
  • Europe-
    • Germany
    • The UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific-
    • China
    • Japan
    • India
    • South Korea
    • South East Asia
    • Rest of Asia Pacific
  • Latin America-
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  •  Middle East & Africa-
    • GCC Countries
    • South Africa
    • Rest of Middle East and Africa

Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Healthcare Cold Chain Logistics Market Snapshot

Chapter 4. Global Healthcare Cold Chain Logistics Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis of Metaverse Industry
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. COVID-19 Impact on Metaverse Industry

Chapter 5. Market Segmentation 1: By Service Line Estimates & Trend Analysis
5.1. By Service Line & Market Share, 2025-2035
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2035 for the following By Type:

5.2.1. Transportation & express
5.2.2. Warehousing & distribution
5.2.3. Packaging & containerization
5.2.4. Temperature monitoring & visibility
5.2.5. Value-added services 
5.2.6. Direct-to-patient / home healthcare logistics
5.2.7. Clinical trial logistics

Chapter 6. Market Segmentation 2: By Temperature Range Estimates & Trend Analysis
6.1. By Temperature Range & Market Share, 2025-2035
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2035 for the following By Temperature Range:

6.2.1. Controlled ambient (15–25 °C)
6.2.2. Refrigerated/cold (2–8 °C)
6.2.3. Frozen (−20/−30 °C)
6.2.4. Deep-frozen (≤−80 °C)
6.2.5. Cryogenic/LN₂ (≤−150 °C; dry vapor shippers) 

Chapter 7. Market Segmentation 3: By Product Type Techniques Estimates & Trend Analysis
7.1. By Product Type & Market Share, 2025-2035
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2035 for the following By Product Type:

7.2.1.1. Small-molecule pharmaceuticals
7.2.1.2. Biologics & vaccines
7.2.1.3. Cell & gene therapies (CGT)
7.2.1.4. Clinical trial materials (IMP, comparators, ancillaries)
7.2.1.5. Diagnostic reagents & biospecimens
7.2.1.6. Blood, plasma & specialty biologics 

Chapter 8. Market Segmentation 3: By Mode Of Transport Estimates & Trend Analysis
8.1. By Mode Of Transport & Market Share, 2025-2035
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2035 for the following By Mode Of Transport:

8.2.1.1. Air
8.2.1.2. Road
8.2.1.3. Ocean
8.2.1.4. Rail
8.2.1.5. Multimodal/intermodal 

Chapter 9. Market Segmentation 3: By Packaging/Container Type Estimates & Trend Analysis
9.1. By Packaging/Container Type & Market Share, 2025-2035
9.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2035 for the following By Packaging/Container Type:

9.2.1.1. Active temperature-controlled ULDs
9.2.1.2. Hybrid containers
9.2.1.3. Passive reusable bulk shippers (pallet)
9.2.1.4. Passive parcel shippers (single-use/reusable)
9.2.1.5. Dry ice & deep-freeze solutions
9.2.1.6. LN₂ dry vapor shippers & cryo dewars
9.2.1.7. Refrigerants (PCM, gel packs) & payload conditioning 

Chapter 10. Market Segmentation 3: By Application Estimates & Trend Analysis
10.1. By Application & Market Share, 2025-2035
10.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2035 for the following By Application:

10.2.1.1. Commercial distribution
10.2.1.2. Clinical trials (phase I–IV)
10.2.1.3. Direct-to-patient & decentralized trials
10.2.1.4. Returns, refurb & reverse logistics
10.2.1.5. Emergency/stock-out mitigation & surge response

Chapter 11. Market Segmentation 3: End-User Estimates & Trend Analysis
11.1. By End-User & Market Share, 2025-2035
11.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2035 for the following By End-User:

11.2.1.1. Pharma & biotech manufacturers
11.2.1.2. Vaccines & biologics producers
11.2.1.3. CDMOs/CMOs
11.2.1.4. CROs/clinical sites & labs
11.2.1.5. Hospitals, blood banks & diagnostics networks
11.2.1.6. Government & NGOs (EPI/UNICEF/PAHO) 

Chapter 12. Healthcare Cold Chain Logistics Market Segmentation 4: Regional Estimates & Trend Analysis
12.1. North America

12.1.1. North America Healthcare Cold Chain Logistics Market revenue (US$ Million) estimates and forecasts By Service Line, 2022-2035
12.1.2. North America Healthcare Cold Chain Logistics Market revenue (US$ Million) estimates and forecasts By Temperature Range, 2022-2035
12.1.3. North America Healthcare Cold Chain Logistics Market revenue (US$ Million) estimates and forecasts By Product Type, 2022-2035
12.1.4. North America Healthcare Cold Chain Logistics Market revenue (US$ Million) estimates and forecasts By Mode of Transport, 2022-2035
12.1.5. North America Healthcare Cold Chain Logistics Market revenue (US$ Million) estimates and forecasts By Packaging, 2022-2035
12.1.6. North America Healthcare Cold Chain Logistics Market revenue (US$ Million) estimates and forecasts By Application, 2022-2035
12.1.7. North America Healthcare Cold Chain Logistics Market revenue (US$ Million) estimates and forecasts By End User, 2022-2035
12.1.8. North America Healthcare Cold Chain Logistics Market revenue (US$ Million) estimates and forecasts by country, 2022-2035

12.1.8.1. U.S.
12.1.8.2. Canada

12.2. Europe

12.2.1. Europe Healthcare Cold Chain Logistics Market revenue (US$ Million) estimates and forecasts By Service Line, 2022-2035
12.2.2. Europe Healthcare Cold Chain Logistics Market revenue (US$ Million) estimates and forecasts By Temperature Range, 2022-2035
12.2.3. Europe Healthcare Cold Chain Logistics Market revenue (US$ Million) estimates and forecasts By Product Type, 2022-2035
12.2.4. Europe Healthcare Cold Chain Logistics Market revenue (US$ Million) estimates and forecasts By Mode of Transport, 2022-2035
12.2.5. Europe Healthcare Cold Chain Logistics Market revenue (US$ Million) estimates and forecasts By Packaging, 2022-2035
12.2.6. Europe Healthcare Cold Chain Logistics Market revenue (US$ Million) estimates and forecasts By Application, 2022-2035
12.2.7. Europe Healthcare Cold Chain Logistics Market revenue (US$ Million) estimates and forecasts By End User, 2022-2035
12.2.8. Europe Healthcare Cold Chain Logistics Market revenue (US$ Million) by country, 2022-2035

12.2.8.1. Germany
12.2.8.2. Poland
12.2.8.3. France
12.2.8.4. Italy
12.2.8.5. Spain
12.2.8.6. UK
12.2.8.7. Rest of Europe

12.3. Asia Pacific

12.3.1. Asia Pacific Healthcare Cold Chain Logistics Market revenue (US$ Million) estimates and forecasts By Service Line, 2022-2035
12.3.2. Asia Pacific Healthcare Cold Chain Logistics Market revenue (US$ Million) estimates and forecasts By Temperature Range, 2022-2035
12.3.3. Asia Pacific Healthcare Cold Chain Logistics Market revenue (US$ Million) estimates and forecasts By Product Type, 2022-2035
12.3.4. Asia Pacific Healthcare Cold Chain Logistics Market revenue (US$ Million) estimates and forecasts By Mode of Transport, 2022-2035
12.3.5. Asia Pacific Healthcare Cold Chain Logistics Market revenue (US$ Million) estimates and forecasts By Packaging, 2022-2035
12.3.6. Asia Pacific Healthcare Cold Chain Logistics Market revenue (US$ Million) estimates and forecasts By Application, 2022-2035
12.3.7. Asia Pacific Healthcare Cold Chain Logistics Market revenue (US$ Million) estimates and forecasts By End User, 2022-2035
12.3.8. Asia Pacific Healthcare Cold Chain Logistics Market revenue (US$ Million) by country, 2022-2035

12.3.8.1. China
12.3.8.2. India
12.3.8.3. Japan
12.3.8.4. Australia
12.3.8.5. Rest of Asia Pacific

12.4. Latin America

12.4.1. Latin America Healthcare Cold Chain Logistics Market revenue (US$ Million) estimates and forecasts By Service Line, 2022-2035
12.4.2. Latin America Healthcare Cold Chain Logistics Market revenue (US$ Million) estimates and forecasts By Temperature Range, 2022-2035
12.4.3. Latin America Healthcare Cold Chain Logistics Market revenue (US$ Million) estimates and forecasts By Product Type, 2022-2035
12.4.4. Latin America Healthcare Cold Chain Logistics Market revenue (US$ Million) estimates and forecasts By Mode of Transport, 2022-2035
12.4.5. Latin America Healthcare Cold Chain Logistics Market revenue (US$ Million) estimates and forecasts By Packaging, 2022-2035
12.4.6. Latin America Healthcare Cold Chain Logistics Market revenue (US$ Million) estimates and forecasts By Application, 2022-2035
12.4.7. Latin America Healthcare Cold Chain Logistics Market revenue (US$ Million) estimates and forecasts By End User, 2022-2035
12.4.8. Latin America Healthcare Cold Chain Logistics Market revenue (US$ Million) by country, (US$ Million) 2022-2035

12.4.8.1. Brazil
12.4.8.2. Rest of Latin America

12.5. Middle East & Africa

12.5.1. Middle East & Africa Healthcare Cold Chain Logistics Market revenue (US$ Million) estimates and forecasts By Service Line, 2022-2035
12.5.2. Middle East & Africa Healthcare Cold Chain Logistics Market revenue (US$ Million) estimates and forecasts By Temperature Range, 2022-2035
12.5.3. Middle East & Africa Healthcare Cold Chain Logistics Market revenue (US$ Million) estimates and forecasts By Product Type, 2022-2035
12.5.4. Middle East & Africa Healthcare Cold Chain Logistics Market revenue (US$ Million) estimates and forecasts By Mode of Transport, 2022-2035
12.5.5. Middle East & Africa Healthcare Cold Chain Logistics Market revenue (US$ Million) estimates and forecasts By Packaging, 2022-2035
12.5.6. Middle East & Africa Healthcare Cold Chain Logistics Market revenue (US$ Million) estimates and forecasts By Application, 2022-2035
12.5.7. Middle East & Africa Healthcare Cold Chain Logistics Market revenue (US$ Million) estimates and forecasts By End User, 2022-2035
12.5.8. Middle East & Africa Healthcare Cold Chain Logistics Market revenue (US$ Million) by country, (US$ Million) 2022-2035

12.5.8.1. South Africa
12.5.8.2. GCC Countries
12.5.8.3. Rest of MEA

Chapter 13. Competitive Landscape
13.1. Major Mergers and Acquisitions/Strategic Alliances
13.2. Company Profiles

13.2.1. DHL
13.2.2. UPS Healthcare
13.2.3. FedEx
13.2.4. Kuehne+Nagel
13.2.5. DB Schenker
13.2.6. DSV
13.2.7. CEVA Logistics
13.2.8. Bolloré Logistics
13.2.9. Nippon Express
13.2.10. Yusen Logistics
13.2.11. Kerry Logistics
13.2.12. SF Express
13.2.13. World Courier
13.2.14. Marken
13.2.15. QuickSTAT
13.2.16. Cryoport
13.2.17. Envirotainer
13.2.18. CSafe Global
13.2.19. DoKaSch Temperature Solutions
13.2.20. SkyCell
13.2.21. Sonoco ThermoSafe
13.2.22. Tower Cold Chain
13.2.23. va-Q-tec
13.2.24. Peli BioThermal
13.2.25. Softbox
13.2.26. Thermo Fisher Scientific
13.2.27. AeroSafe Global
13.2.28. Intelsius
13.2.29. Cold Chain Technologies
13.2.30. Sensitech
13.2.31. ELPRO
13.2.32. Berlinger
13.2.33. Controlant
13.2.34. Tive
13.2.35. PHCbi
13.2.36. Haier Biomedical
13.2.37. Helmer Scientific
13.2.38. Azenta Life Sciences

Research Design and Approach

This study employed a multi-step, mixed-method research approach that integrates:

  • Secondary research
  • Primary research
  • Data triangulation
  • Hybrid top-down and bottom-up modelling
  • Forecasting and scenario analysis

This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.

Secondary Research

Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.

Sources Consulted

Secondary data for the market study was gathered from multiple credible sources, including:

  • Government databases, regulatory bodies, and public institutions
  • International organizations (WHO, OECD, IMF, World Bank, etc.)
  • Commercial and paid databases
  • Industry associations, trade publications, and technical journals
  • Company annual reports, investor presentations, press releases, and SEC filings
  • Academic research papers, patents, and scientific literature
  • Previous market research publications and syndicated reports

These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.

Secondary Research

Primary Research

Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.

Stakeholders Interviewed

Primary interviews for this study involved:

  • Manufacturers and suppliers in the market value chain
  • Distributors, channel partners, and integrators
  • End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
  • Industry experts, technology specialists, consultants, and regulatory professionals
  • Senior executives (CEOs, CTOs, VPs, Directors) and product managers

Interview Process

Interviews were conducted via:

  • Structured and semi-structured questionnaires
  • Telephonic and video interactions
  • Email correspondences
  • Expert consultation sessions

Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.

Data Processing, Normalization, and Validation

All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.

The data validation process included:

  • Standardization of units (currency conversions, volume units, inflation adjustments)
  • Cross-verification of data points across multiple secondary sources
  • Normalization of inconsistent datasets
  • Identification and resolution of data gaps
  • Outlier detection and removal through algorithmic and manual checks
  • Plausibility and coherence checks across segments and geographies

This ensured that the dataset used for modelling was clean, robust, and reliable.

Market Size Estimation and Data Triangulation

Bottom-Up Approach

The bottom-up approach involved aggregating segment-level data, such as:

  • Company revenues
  • Product-level sales
  • Installed base/usage volumes
  • Adoption and penetration rates
  • Pricing analysis

This method was primarily used when detailed micro-level market data were available.

Bottom Up Approach

Top-Down Approach

The top-down approach used macro-level indicators:

  • Parent market benchmarks
  • Global/regional industry trends
  • Economic indicators (GDP, demographics, spending patterns)
  • Penetration and usage ratios

This approach was used for segments where granular data were limited or inconsistent.

Hybrid Triangulation Approach

To ensure accuracy, a triangulated hybrid model was used. This included:

  • Reconciling top-down and bottom-up estimates
  • Cross-checking revenues, volumes, and pricing assumptions
  • Incorporating expert insights to validate segment splits and adoption rates

This multi-angle validation yielded the final market size.

Forecasting Framework and Scenario Modelling

Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.

Forecasting Methods

  • Time-series modelling
  • S-curve and diffusion models (for emerging technologies)
  • Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
  • Price elasticity models
  • Market maturity and lifecycle-based projections

Scenario Analysis

Given inherent uncertainties, three scenarios were constructed:

  • Base-Case Scenario: Expected trajectory under current conditions
  • Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
  • Conservative Scenario: Slow adoption, regulatory delays, economic constraints

Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.

Name field cannot be blank!
Email field cannot be blank!(Use email format)
Designation field cannot be blank!
Company field cannot be blank!
Contact No field cannot be blank!
Message field cannot be blank!
6014
Security Code field cannot be blank!

Frequently Asked Questions

Healthcare Cold Chain Logistics Market Size is valued at USD 64.63 billion in 2025 and is predicted to reach USD 149.65 billion by the year 2035

Healthcare Cold Chain Logistics Market expected to grow at a 8.8% CAGR during the forecast period for 2026 to 2035.

AmerisourceBergen Corporation (U.S.), CAVALIER LOGISITICS (U.S.), Continental Carbon Company (U.S.), DHL International GmbH (Germany), FedEx (U.S.), Kuehne+Nagel (Germany), Deutsche Post AG (Germany), LifeConEx (U.S.), American Airlines Inc. (U.S.) Air Charter Service (India), Agility Public Warehousing Company (U.S.), VersaCold Logistics Services (Canada), Delhivery Limited (India), YUSEN LOGISTICS CO., LTD. (India), V-Xpress (India), FulfillmentHubUSA (U.S.), Prompt Brazil Logistics (Brazil) and Others.

Healthcare Cold Chain Logistics Market is Segmented in Type (Biopharmaceuticals, Vaccines, Clinical Trial Materials, Others), Services (Storage, Transportation, Packaging, Others), Storage Techniques (Electrical refrigeration, Dry Ice, Gel Packs, Liquid Nitrogen, Others), Product Type, Application, Temperature Range, Mode Of Transport and other.

North American region is leading the Healthcare Cold Chain Logistics Market.
Get Sample Report Enquiry Before Buying